Market Overview

UPDATE: Morgan Stanley Cuts PT to $42 on MetLife Following Guidance

Related MET
Visa Says Charlie Scharf Out As CEO; Alfred Kelly Named Replacement
Metlife's Retail Spinoff Still On Track
Don't Worry, It's About To Get Worse (Seeking Alpha)

Morgan Stanley reiterated its Overweight rating on MetLife (NYSE: MET) but lowered its price target from $44 to $42.

Morgan Stanley noted, "MetLife's guidance was modestly disappointing, with both EPS and capital expectations running somewhat below our expectations. That said, their guidance is typically conservative (they typically hit at least the high end), and even with lowered numbers, the valuation multiple on stock is very low."

MetLife closed at $33.61 on Wednesday.

Latest Ratings for MET

Oct 2016Credit SuisseInitiates Coverage onNeutral
Jul 2016Deutsche BankDowngradesBuyHold
Jul 2016CitigroupMaintainsNeutral

View More Analyst Ratings for MET
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (MET)

View Comments and Join the Discussion!